Actively Recruiting
Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement
Led by Institut Pasteur · Updated on 2024-03-15
40
Participants Needed
1
Research Sites
131 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affecting auditory sensitivity. There is a need to find ad-hoc denoising methods, based on the expert knowledge of audiologists, to improve the noise comprehension performance of these patients. Implemented denoising methods, based on artificial intelligence, will also greatly benefit more standard hearing loss cases.
CONDITIONS
Official Title
Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than or equal to 18 years
- French mother tongue
- Have an average tonal hearing loss (calculated according to the BIAP method) < 30 dB HL, on headphones, for each ear
- Be professionally active, not be pre-retired and not be unemployed
- Be affiliated with a social security plan
- For participants with TSNA: Have degraded comprehension in noise (threshold of Intelligibility in Noise > 3 dB compared to the norm)
- For controls: Have normal comprehension in noise (Intelligibility in Noise threshold �3d 3 dB from the norm)
You will not qualify if you...
- Have a conductive or mixed hearing loss, which is when the hearing loss affects both the outer and/or middle ear and the inner ear
- Have an asymmetric hearing loss, i.e. a difference in average hearing loss between the left and right ear greater than 30 dB
- Have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing (vestibular schwannoma, Meniere's disease, sudden or fluctuating deafness, congenital hypoacusis)
- Being under guardianship
- Being deprived of liberty by judicial or administrative decision, or being subject to legal protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CEntre de Recherche et d'Innovation en Audiologie Humaine
Paris, France
Actively Recruiting
Research Team
M
Marta Campi, PhD
CONTACT
P
Paul Avan, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here